Validation of current inventory of Materials for distribution and sales

Filing of BLA with FDA for Acute Radiation Syndrome

Total Acute Radiation Syndrome Development Milestones

File IND and Initiate Phase 2 Clinical Study for Neutropenia

Phase III Completion - successfully meets endpoint required to secure FDA approval for treatment of Neutropenia

File BLA with FDA and achieve FDA Approval for Neutropenia

File IND and Initiate Phase 2 study of Lymphocyte Exhaustion

Phase III Completion - successfully meets endpoint required by FDA for treatment of Lymphocyte Exhaustion

File BLA with FDA and achieve FDA Approval for Lymphocyte Exhaustion

IND approval and initiation of Phase 3 study as a Vaccine Adjuvant

File US BLA with FDA and achieve FDA Approval for use as a Vaccine Adjuvant

Total Potential Development Milestones for additional Indications (as applicable)